Nature World News reports that the U.S. Food and Drug Administration has approved the anti-cholesterol drug Liptruzet.
According to the story, Liptruzet is a combination of Merck’s Zetia, which lowers low-density lipoprotein (LDL), and a generic version of Pfizer’s Lipitor, which lost its patent protection in 2011.
Lipitor has recently generated some health concerns.
The U.S. Food and Drug Administration has added warnings to Lipitor’s label, advising that the medication may increase the ...
continue reading...
A report on News Channel 4 out of Oklahoma tells the story of a woman who received a vaginal mesh implant in the belief that it was the most advanced, minimally invasive technique available to cure her urinary incontinence.
CBS News reports on a U.S. Food and Drug Administration warning that medications containing valproate sodium may cause lower IQs in children born to women who take them.
An American plaintiff awarded $11.1 million in court because of her injuries from a vaginal mesh implant is lending her support to women seeking similar legal redress in Scotland and the U.K., according to a story in the Scots paper Daily Record.
A story posted on the Website of KTRK-TV out of Houston deals with U.S. Food and Drug Administration investigation into a potential link between newer diabetes drugs including Byetta and Januvia, and a potentially dangerous condition called pancreatitis.
